Provided by Tiger Fintech (Singapore) Pte. Ltd.

COEPTIS THERAPEUTICS HOLDINGS INC

8.15
-0.1500-1.81%
Post-market: 8.150.00000.00%17:57 EDT
Volume:50.87K
Turnover:411.25K
Market Cap:27.42M
PE:-1.60
High:8.50
Open:8.13
Low:7.75
Close:8.30
Loading ...
Aug 16, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Jul 31, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 25, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Mar 25, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Mar 25, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Dec 22, 2023

Major Issues Report

Form 8-K - Current report
Dec 05, 2023

Major Issues Report

Form 8-K - Current report
Nov 28, 2023

Correspondence

Form CORRESP - Correspondence
Nov 15, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2023

Major Issues Report

Form 8-K - Current report
Oct 13, 2023

Major Issues Report

Form 8-K - Current report